All News
What happens to #Sjogrens tests over time? Well nothing- serology and tests are stable over time for NIH in >2800 Pts from 1984-2020 in well characterized Pts. Abst#2025 #ACR22 @RheumNow I was surprised as I thought there would be worsening but if prevalent Pts already fibrotic?
Janet Pope Janetbirdope ( View Tweet)
Wheeler et al. MUC5B assoc risk RA-ILD, OR 2.25. No significant additive interaction with race, smoking, disease activity @RheumNow #ACR22 Abstr#2250 https://t.co/Hw2oBawKsd https://t.co/DqCQIPpEyg
Richard Conway RichardPAConway ( View Tweet)
Abstr #2195 COVID PrEP in Rheum pts who did not seroconvert after 3rd dose
- anti-SARS-CoV2 IgG levels ↑ after day 1
- Saliva IgG also ↑ up to day 14
- one reported COVID+ w mild symptoms
@RheumNow #ACR22 https://t.co/um2JFNMhpj
Akhil Sood MD AkhilSoodMD ( View Tweet)
Zuo @RayZuoMD @jasonsknight et al. High levels of anti-NET antibodies in 45% of aPL-positive patients May activate the complement cascade and contribute to brain white matter changes. @RheumNow #ACR22 Abstr#2269 https://t.co/JrjNvQRDim https://t.co/c4yXHLOmBJ
Richard Conway RichardPAConway ( View Tweet)
ILD in #scleroderma. #Scleroderma lung study III - NO DIFF between MMF + Pirfenidone vs MMF alone. Planned for 150 Pts but only 51 enrolled but p=0.9. A trial recruited during #COVID so difficult to enroll Abst#530 @RheumNow #ACR22 https://t.co/CBYEJ2YCVM
Janet Pope Janetbirdope ( View Tweet)
How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a difference? @RheumNow #ACR22
https://t.co/2oJ1RAeciN https://t.co/c9s6QRSOR4
Catherine Sims, MD DrCassySims ( View Tweet)
Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow #ACR22 Abstr#2251 #ACRbest https://t.co/R5rQ3KcHnq https://t.co/8Nq0t4zqQK
Richard Conway RichardPAConway ( View Tweet)
#Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, less infections if 600 mg IV fixed q6 mo how long to continue? Abst#1084 and less flares w Rituximab maintenance in the MAINRITSAN studies abst#527 Ritux is new SoC in GPA @RheumNow
Janet Pope Janetbirdope ( View Tweet)
Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in CDASI (both activity and damage) and SF-36. @RheumNow #ACR22 Abstr#2239 https://t.co/vsnvYUla13
Richard Conway RichardPAConway ( View Tweet)
Let's review how GCs induce #Osteoporosis 👇(every Rheum should know this!)
💊GCs have bone cell specific effects on:
💠Osteoclasts ⬆️resorption, survival
💠Osteoblasts ⬇️🦴formation & prolif; ⬆️apoptosis
💠Osteocytes ⬆️apoptosis & skeletal fragility
#ACR22 @RheumNow @rheumarhyme https://t.co/n61OXkmRgr
sheila RHEUMarampa ( View Tweet)
Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>seronegative>other abs @RheumNow #ACR22 Abstr#2241 https://t.co/g8xTRyw6NZ https://t.co/sR1tT2QmU3
Richard Conway RichardPAConway ( View Tweet)
BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half of pts w/ active PsA who are bDMARD-naïve or TNFi-IR. Abs 2119 #ACR22 @RheumNow https://t.co/29gzmMZRlG https://t.co/qziqGNxQih
Dr. Rachel Tate uptoTate ( View Tweet)
After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further studies needed to perform survival subgroup analysis regarding different extra-articular manifestations and PsA subtypes. Abs 2149 #ACR22 @RheumNow https://t.co/SRPhSiGeUI https://t.co/EYDULe52A3
Dr. Rachel Tate uptoTate ( View Tweet)
Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @RheumNow #ACR22 Abstr#2252 https://t.co/woVErubytC https://t.co/r916r1AxtN
Richard Conway RichardPAConway ( View Tweet)
More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow https://t.co/OrrDWfvGty https://t.co/CdCQzmgOOO
Dr. Rachel Tate uptoTate ( View Tweet)
🌟 COVAX register 🌟
🦠flares of IMRD following covid vax uncommon
👉factors associated with flare:
⬆️disease activity
🙋♀️ female
💊no DMARD @ vax
💊stop/⬇️ DMARD @ vax
👉⬇️ flare assoc with:
💥young
💉RTX
@RheumNow #ACR22 Abst #2274 https://t.co/S892lKcEvS
Patricia Harkins DrTrishHarkins ( View Tweet)
Long term RZB provides durable efficacy response in PsA through 100 weeks. No new safety signals. Abs 2145 #ACR22 @RheumNow https://t.co/HfJvS1HzDW https://t.co/T67lDnxeLy
Dr. Rachel Tate uptoTate ( View Tweet)
Updated ACR GIOP guidelines:
Panel recommends doing Initial fracture risk assessment using the CLINICAL fracture risk assessment then RE-assessing while pts continue on GCs (👇)
☝️Magic nos. GC>/= 2.5mg/d for >3mos
#ACR22 @RheumNow @rheumarhyme #Osteoporosis https://t.co/7oWqHg8Tdv
sheila RHEUMarampa ( View Tweet)
Connolly @CaoilfhionnMD et al. 3 doses SARS-CoV-2 vaccine assoc reduced breakthrough infection in Omicron wave in RMD patients. @RheumNow #ACR22 Abstr#2275 https://t.co/ONXiY8JShK https://t.co/QHNYG9XuJ0
Richard Conway RichardPAConway ( View Tweet)
Wilson et al. Sputum levels of TGF-β1, TNF-α, MCP-1, and IL-4 are significantly elevated in RA-ILD and a portion of these cytokines are also increased in subclinical disease and correlated with lung physiology @RheumNow #ACR22 Abstr#2253 https://t.co/V1fG0QC9od https://t.co/d2YvVIV3Jq
Richard Conway RichardPAConway ( View Tweet)